Latest
04
Sep
Fund of the week: The Clinique La Prairie Longevity Fund
Fund Launch and Structure
Clinique La Prairie, the Swiss medical spa founded in 1931, launched its Longevity Fund in October
6 min read
03
Sep
AI Models in Biotechnology: 2025 Market Analysis and Performance Assessment
Executive Summary
The integration of artificial intelligence into biotechnology has reached a critical inflection point in 2025. This comprehensive analysis
8 min read
02
Sep
Using Generative AI to Create Synthetic Data in Biotech and Pharma
Executive Summary: The $7.8 billion question
The generative AI revolution in biotech synthetic data generation stands at a critical
13 min read
01
Sep
Yamanaka factors and the reprogramming paradox
The promise of cellular reprogramming through Yamanaka factors represents one of the most profound scientific contradictions in modern medicine: a
8 min read
31
Aug
The weekly term sheet (35)
Weekly Term Sheet: Pharma & Biotech Deals (August 25–28, 2025)
Key Deal Highlights
Deal Type
Companies
Value
Key Asset/
7 min read
30
Aug
Biosimilar Patent Infringement Cases in 2025 Amid a Looming Patent Cliff
Introduction: A Wave of Biosimilar Challenges and the "Patent Cliff"
The biopharmaceutical industry is witnessing a surge of
8 min read
29
Aug
Bristol Myers Squibb's $300 Million Autoimmune Spinout – Investors, Precedents, and Financing Structure
Investor Syndicate and Stakeholders in the $300 Million Round
The new biotech (not yet officially named) is backed by a
9 min read
28
Aug
Fund of the week: DRI Healthcare
Origin Story: From Niche Pioneer to Public Trust
DRI Healthcare's roots go back to 1989, when it began
27 min read
27
Aug
Private equity biotech investment landscape in Q3 2025
The biotech investment ecosystem in late August 2025 presents a complex landscape of cautious recovery, selective capital deployment, and strategic
13 min read
26
Aug
The psychedelics sector faces a brutal financial reckoning as cash burn rates collide with regulatory setbacks
The psychedelics industry entered August 2025 with approximately $1.2 billion in combined cash reserves across six major public companies,
15 min read